Spots Global Cancer Trial Database for Exercise Prehab in Older Adults With Hematologic Malignancies

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Exercise Prehab in Older Adults With Hematologic Malignancies

Official Title: Maintaining Fitness: Exercise in Patients With Hematologic Malignancy

Study ID: NCT02791737

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Interventions

Exercise Intervention

Laboratory Biomarker Analysis

Physical Therapy

Quality-of-Life Assessment

Questionnaire Administration

Study Description

Brief Summary: This pilot trial studies a structured exercise program intervention in improving physical activity in older patients with hematologic malignancies undergoing cancer therapy. Patients with hematologic malignancies are at an increased risk of functional dependence and injury. Structured exercise programs, such as the Otago exercise programme (OEP), may improve balance, strength, and prevent fall-related injury in older patients with hematologic malignancies undergoing cancer therapy.

Detailed Description: PRIMARY OBJECTIVES: I. To assess the feasibility of implementing a structured exercise program by evaluating recruitment and retention, exercise program adherence, sustainability, adverse events, and implementation challenge. SECONDARY OBJECTIVES: I. To calculate preliminary effect sizes of the impact of an exercise program in patients with hematologic malignancy undergoing therapy, as measured by: * Cancer and Aging Research Group (CARG) Geriatric Assessment Tool parameters. * Change in Short Physical Performance Battery (SPPB). * Number and severity of falls. * Impact of motivation and self-efficacy on adherence. * Hospital readmission rates (if applicable). * Length of inpatient stays (if applicable). * Patient Reported Outcome Measurement Information System (PROMIS) for Health related quality of life (HRQL). * Correlative analysis of peripheral blood biomarkers of aging and inflammation (cyclin-dependent kinase inhibitor 2A \[p16\], inflammatory biomarkers, immunosenescence, micro \[mi\] ribonucleic acid \[RNA\]). OUTLINE: Patients attend 8 physical therapy visits twice monthly for 4 months or until transplant. Patients also undergo an individualized exercise program at home for 6 months. The program comprises 3 main components: walking over 30 minutes twice a week, strengthening and balance retraining exercise over 30 minutes three times a week. After completion of study, patients are followed up at 6 months.